BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 14, 2005
View Archived Issues
Neuropeptide Y Y2 antagonist effective in rats with ethanol dependence
Read More
Neuroprotective effects of thiazolidinediones in a preclinical model of stroke
Read More
RP-101 reported to improve survival in patients with advanced pancreatic cancer
Read More
Phase II data on the benefits of PT-141 in female sexual dysfunction
Read More
Putative antidepressant LY-367265 inhibits glutamate release in rat cortex
Read More
Update on the efficacy of rasburicase in the prevention of hyperuricemia in cancer patients
Read More
Ondansetron improves auditory gating in schizophrenic patients
Read More
Positive findings in phase II study of ProMune plus chemotherapy in NSCLC
Read More
ReceptoPharm plans phase IIb/III study of RPI-78M in adrenomyeloneuropathy
Read More
Phase IIb/III DIAS2 study begins for desmoteplase in acute ischemic stroke
Read More
Boehringer Ingelheim discontinues development of bivatuzumab mertansine
Read More
Adderall XR sales suspended in Canada
Read More
Pharmacokinetic study of TRANSDUR-based sufentanil patch completes dosing
Read More
Phase II study of Durect's postoperative pain relief depot product progresses
Read More
Positive phase III results for Nuvigil
Read More
XP-13512 enters phase IIb study for restless legs syndrome
Read More
SPA agreement for phase III study of Cloretazine in relapsed AML
Read More
Vical completes SPA for Allovectin-7
Read More
SOT-107 receives Japanese orphan drug status
Read More
Three series of chemokine CCR4 receptor modulators claimed by AstraZeneca
Read More
New anticoagulant agents reported by Bristol-Myers Squibb
Read More
Aventis imparts new tubulin polymerization inhibitors for cancer therapy
Read More
Novel antiinflammatory chalcones patented by AtheroGenics
Read More
Bristol-Myers Squibb patent covers new antiinflammatory agents
Read More
Metabotropic glutamate (mGluR5) receptor antagonists described in patent literature
Read More
First anti-HIV dual CCR5/CXCR4 antagonist described / News in Context
Read More
New title added to the Drug R&D Backgrounders topic list - Osteoarthritis
Read More